CDKN2A and head and neck squamous cell carcinoma: Interestingly, we did not find any significant association between TP53 mutations and mRNA expression of selected targets: BAX, PUMA, CDKN1A, and CDKN2A. In the light of the recent work by (73) this finding is in line with the HNSCC expression profile.